A new article from an Australian clinical research group in the journal Andrology addresses “the effectiveness of implementing standardized guidelines to mitigate metabolic and bone side effects of androgen deprivation therapy (ADT) in men with non-metastatic prostate cancer.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, bone, density, deprivation, metabolic syndrome, outcome | 1 Comment »
Metabolic syndrome has been implicated in the development of prostate cancer, but there have been no published data on whether it affects the effectiveness of androgen deprivation therapy (ADT). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, metabolic syndrome, outcome, survival | Leave a comment »
Metabolic syndrome is increasingly prevalent in the USA and in other parts of the “westernized” world and consists of a cluster of conditions that are known risk factors for cardiovascular disease (obesity, high cholesterol levels, pre-diabetes, etc.). Several recent reports have also linked metabolic syndrome to prostate cancer — but have not had racially diverse populations to explore differences in risk. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: ethnicity, metabolic syndrome, risk | 2 Comments »
Today’s news reports address:
Filed under: Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk | Tagged: drinking, exercise, magnetic resonance imaging, metabolic syndrome, MRI, prognosis, smoking | Leave a comment »
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
Blog at WordPress.com. WP Designer.
THE "NEW" PROSTATE CANCER INFOLINK